ReviewArchives of microbiology2025
Recent strategies and methodological advances for microbial natural product research in the post-genomics era.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anticancer natural products from the Middle East and North Africa: biodiversity, mechanisms, and translational challenges.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microorganisms remain a prolific source of bioactive compounds, yet discovery efforts are often hindered by traditional methods and the repeated isolation of known molecules. In the post-genomics era, advances in genome mining and multi-omics technologies have revealed the hidden potential of biosynthetic gene clusters. A major challenge, however, lies in reliably linking these gene clusters to their metabolites and in the activation of silent pathways. This review summarizes recent breakthroughs addressing these challenges, focusing on the most recent case studies (up to 2025), and covering three interconnected themes. First, it reviews the current strengths and limitations of microbial genomics and artificial intelligence in natural product discovery, emphasizing different genome-guided discovery strategies and the emerging applications of artificial intelligence. Second, it highlights strategies for activating silent gene clusters, covering both untargeted and targeted approaches. Third, it discusses the expansion of chemical diversity through bioprospecting in underexplored ecological niches, the integration of sustainable, ethically informed practices, and the development of novel cultivation platforms. By synthesizing these advances, this review provides a forward-looking perspective, proposing how the integration of current tools in one framework can establish a predictive and potentially highly efficient method for linking biosynthetic gene clusters to their metabolites. Such integrative approaches may accelerate the discovery of microbial natural products and contribute sustainable solutions to global health challenges, including antimicrobial resistance. In conclusion, this review represents an up-to-date roadmap for researchers in microbial natural product research from a biological perspective, identifies existing strengths and knowledge gaps, and highlights promising, proof-of-concept strategies that can drive future advances in the field.
Indexed as
Identifiers
41313478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.